19 Compelling Reasons That May Make Reckitt Benckiser plc A Buy

Royston Wild reveals why shares in Reckitt Benckiser plc (LON: RB) look set to stride higher.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am explaining why I believe shares in Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) are set to march higher on the back of its powerful portfolio of household brands.

Blockbuster brands to deliver bountiful gains

Shares in household goods giant Reckitt Benckiser have shot higher in recent weeks, leaping more than 11% since in just over a fortnight and boosted by bubbly third-quarter financial results. Net revenues, on a constant currencies basis, rose 6% in the January-September period to £7.54bn, the company said.

And in my opinion the firm can look forward to further excellent revenues growth, with its galloping emerging market exposure and portfolio of industry-leading ‘Powerbrands‘ leading the charge. In particular, I believe that the strength of these 19 self-monikered labels are key to the firm’s future expansion story.

Reckitt Benckiser’s stable of premier labels are sold in more than 200 countries and include the likes of dishwasher cleaner Finish, sore throat reliever Strepsils and condom brand Durex, all three of which are the most popular global brands in their fields. And Reckitt Benckiser’s successful roll-out of these labels in new markets, combined with novel innovations across a multitude of these brands, are helping to drive revenues higher.

Indeed, brand strength here is helping to drive the firm’s push into exciting emerging regions, and Reckitt Benckiser saw turnover in Latin America, Asia Pacific, Australasia and China rise 10% in January-September. These labels also helped to deliver 7% growth in otherwise-stagnant Western consumer markets during the period — the firm’s Mucinex chest congestion product and Lysol disinfectant line were mainly responsible for growth in North America during July-September, for example.

Many commentators believe that recent share price strength has worsened Reckitt Benckiser’s already bloated valuation and thus investment appeal. The business was recently dealing on a forward P/E multiple of 18.1, comfortably surpassing a corresponding readout of 15.3 for the complete household goods and home construction sector.

Still, I believe that the company is a great pick for those seeking the security of dependable and chunky earnings growth year after year — indeed, earnings per share have grown at a compound annual growth rate of 10.7% over the past five years. Reckitt Benckiser’s heavyweight Powerbrands have the ability to not only deliver strong revenues growth, but also maintain its encouraging margin story, a critical earnings safety net in the event of a fresh macroeconomic slowdown.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in Reckitt Benckiser.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »